Dublin, Feb. 06, 2026 (GLOBE NEWSWIRE) -- The "Biobanking Market Report 2025-2035" report has been added to ResearchAndMarkets.com's offering.
This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Accelerated Market Growth Driven by Multi-Omics and AI Integration
The global biobanking market-valued at US$83.1 billion in 2025 and projected to reach US$194.0 billion by 2035 is accelerating as the sector transitions from conventional sample storage to large-scale, data-rich, multi-omics and AI-enabled research infrastructure. Historically centred on limited academic repositories, biobanks have evolved into globally interconnected platforms managing millions of high-quality samples linked to clinical, genomic, and proteomic datasets.
This transformation reflects a broader industry shift toward the active utilisation of biospecimens in sequencing, biomarker discovery, drug development, and translational medicine. Large national and institutional initiatives-such as advanced proteomic mapping involving hundreds of thousands of samples demonstrate the sector's expanding role.
Notably, on 13 January 2025, Illumina announced a pilot proteomics programme analysing 50,000 UK Biobank samples alongside deCODE Genetics, Standard BioTools, Tecan, GSK, Johnson & Johnson, and Novartis, leveraging its next-generation Illumina Protein Prep,N platform. Such collaborations highlight how modern biobanks are becoming critical engines for precision medicine, disease-risk analysis, and long-term population health research, driving robust market expansion.
What would be the Impact of US Trade Tariffs on the Global Biobanking Market?
U.S. trade tariffs are exerting upward pressure on cost structures across the biobanking value chain, particularly for imported ultra-low-temperature freezers, cryogenic systems, automation modules, consumables, and LIMS-related hardware. These cost increases are prompting biobanks to reassess procurement and shift toward regional or tariff-exempt suppliers to maintain budget stability.
The tariffs are also slowing infrastructure upgrades, delaying expansion timelines, and constraining capital allocation for advanced automation and digitalisation projects. In response, global suppliers are restructuring manufacturing footprints, while service providers adjust pricing for storage and processing to offset rising costs. Overall, the tariff environment is accelerating trends toward localisation, multi-vendor sourcing, and financially disciplined operational planning across the biobanking sector.
Key Questions Answered
- How is the Biobanking market evolving?
- What is driving and restraining the Biobanking market?
- How will each Biobanking submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2035?
- How will the market shares for each Biobanking submarket develop from 2025 to 2035?
- What will be the main driver for the overall market from 2025 to 2035?
- Will leading Biobanking markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
- How will the market shares of the national markets change by 2035 and which geographical region will lead the market in 2035?
- Who are the leading players and what are their prospects over the forecast period?
- What are the Biobanking projects for these leading companies?
- How will the industry evolve during the period between 2025 and 2035? What are the implications of Biobanking projects taking place now and over the next 10 years?
- Is there a greater need for product commercialisation to further scale the Biobanking market?
- Where is the Biobanking market heading and how can you ensure you are at the forefront of the market?
- What are the best investment options for new product and service lines?
- What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the Biobanking market today, and over the next 10 years:
- This 355-page report provides 121 tables and 182 charts/graphs exclusively to you.
- The report highlights key lucrative areas in the industry so you can target them - NOW.
- It contains in-depth analysis of global, regional and national sales and growth.
- It highlights for you the key successful trends, changes and revenue projections made by your competitors.
- Forecasts to 2035 and other analyses reveal commercial prospects
- In addition to revenue forecasting to 2035, the new study provides you with recent results, growth rates, and market shares.
- You will find original analyses, with business outlooks and developments.
- Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter's Five Forces Analysis, PEST Analysis and recent developments.
Market Dynamics
Market Driving Factors
- Increased Focus on Precision Medicine and Genetic Testing
- Growing Demand for Umbilical Cord Blood Banking
- Evolution of Biobanks Rapidly Enabling Massive Collections of Biological Materials and Associated Information
Market Restraining Factors
- Private Sponsorship Has Raised a Number of Ethical Issues
- Issues Related to Biospecimen Sample Procurement
- Long-term Sustainability of Biobanks
Market Opportunities
- Human Biospecimens are Essential for Progress in Biomarker Discovery and Customised Treatment
- Opportunities for Cardiovascular Research
- Growing Focus on the R&D of Cell Therapies
U.S. Tariffs: What's the Impact on Global Biobanking Market?
- Overview
- V-Shaped Recovery Scenario
- Why V-Shaped Recovery?
- Impact from Tariffs
- Market Dynamics and Demand Recovery
- Policy and Funding Support
- Timeframe for Recovery
- U-Shaped Recovery Scenario
- Why U-Shaped Recovery?
- Impact from Tariffs
- Market Dynamics and Demand Recovery
- Policy and Funding Support
- Timeframe for Recovery
- L Shaped Recovery Scenario
- Why L-Shaped Recovery?
- Impact from Tariffs
- Market Dynamics and Demand Recovery
- Policy and Funding Support
- Timeframe for Recovery
- What Strategic Considerations Should Clients Factor into Their Near-term (2025-2030) and Long-term (2025-2035) Planning?
- Impact of U.S. and China Trade War on Biobanking Market
- How Might the Most Impacted Countries Experience Positive and Negative Effects Resulting from These Policy Changes?
Porter's Five Forces Analysis
PEST Analysis
Companies Featured
- ASKION GmbH
- Avantor, Inc.
- Azenta Inc.
- BD
- BioIVT
- Boca Biolistics
- Charles River Laboratories International, Inc.
- Cryoport, Inc.
- CTIBiotech
- Hamilton Company
- ISENET
- Labcorp
- Merck KGaA
- PHC Holdings Corporation
- ProteoGenex Inc.
- QIAGEN
- SciSafe
- STEMCELL Technologies
- Tecan Trading AG
- Thermo Fisher Scientific Inc.
- US Biolab Corporation
- Brain Canada
- Cellular Highways Ltd.
- Clairvest Group Inc.
- CorestemChemon
- CytoMed Therapeutics
- Elucidata
- Handok Biotech Co. LTD.
- Haier Biomedical
- Inside Precision Medicine
- Macrogen
- Metabolon
- Propagenix Inc.
- Regeneron Pharmaceuticals
- Sapien Biosciences
- Truveta
- TTP Group Ltd.
- ZenBio Inc.
- Australasian Biospecimen Network (ABN)
- Asian Biological Resource Center Network (ABRCN)
- Biobank India Foundation (BBIF)
- Biobanking and Biomolecular Resources Research Infrastructure (BBMRI)
- Canadian Tissue Repository Network (CTRN)
- Common Access to Biological Resources and Information (CABRI)
- Euro Bio Bank
- European and Middle Eastern Society for Biopreservation and Biobanking (ESBB)
- European Association of Tissue Banks (EATB)
- European Network of Biobanks
- Global Directory of Biobanks, Tissue Banks and Biorepositories
- H3Africa (Human Heredity & Health in Africa)
- IARC Biobank (International Agency for Research on Cancer)
- International Society for Biological and Environmental Repositorys (ISBER)
- Public Population Project in Genomics (P3G)
- Spanish Association of Tissue Banks (AEBT)
- UK Biobank
For more information about this report visit https://www.researchandmarkets.com/r/gewsz7
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
